Induction of inflammatory cytokines by cartilage extracts

International Immunopharmacology

Volumn 7, Issue 3, 2007, Pages 383-391

  Merly, Liza ^a   Simjee, Shabana ^a   Smith, Sylvia L ^a  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

CAM; Cytokine; Immunomodulation; Natural product; Shark cartilage

Indexed keywords

ACID; CARTILADE; CHEMOKINE; CHONDROITIN SULFATE; CHYMOTRYPSIN; COLLAGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4; NATURAL; SHARK CARTILAGE EXTRACT; TISSUE EXTRACT; TRYPSIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CARTILAGE; CELL CULTURE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DIET SUPPLEMENTATION; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE; PATHOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; TH1 CELL;

ANIMALS; CARTILAGE; CYTOKINES; HUMANS; INTERFERON TYPE II; INTERLEUKIN-1BETA; INTERLEUKIN-4; INTERLEUKIN-8; TISSUE EXTRACTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33846582494     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2006.11.011     Document Type: Article

References (32)

1. Eisenberg D.M., Davis R.B., Ettner S.L., Appel S., Wilkey S., et al. Trends in alternative medicine use in the United States, 1990-1997 - results of a follow-up national survey. JAMA 280 18 (1998) 1569-1575
2. Kennedy J. Herb and supplement use in the US adult population. Clin Ther 27 11 (2005) 1847-1858
3. Tindle H.A., Davis R.B., Phillips R.S., and Eisenberg D.M. Trends in use of complementary and alternative medicine by US adults: 1997-2002. Altern Ther Health Med 11 1 (2005) 42-49
4. Oneschuk D., Fennell L., Hanson J., and Bruera E. The use of complementary medications by cancer patients attending an outpatient pain and symptom clinic. J Palliat Care 14 4 (1998) 21-26
5. Suarez-Almazor M., Kendall C.J., and Dorgan M. Surfing the Net-Information on the World Wide Web for persons with arthritis: patient empowerment or patient deceit?. J Rheumatol 28 1 (2001) 185-191
6. Brem H., and Folkman J. Inhibition of tumor angiogenesis mediated by cartilage. J Exp Med 141 (1975) 427-439
7. Lee A., and Langer R. Shark cartilage contains inhibitors of tumor angiogenesis. Science 221 (1983) 1185-1187
8. Oikawa T., Ashino-Fuse H., Shimamura M., Koide U., and Iwaguchi T. A novel angiogenic inhibitor derived from Japanese shark cartilage (I). Extraction and estimation of inhibitory activities toward tumor and embryonic angiogenesis. Cancer Lett 51 3 (1990) 181-186
9. Gingras D., Renaud A., Mousseau N., and Beliveau R. Shark cartilage extracts as antiangiogenic agents: smart drinks or bitter pills?. Cancer Metastasis Rev 19 (2000) 83-86
10. Gonzalez R.P., Leyva A., and Moraes M.O. Shark cartilage as source of antiangiogenic compounds: from basic to clinical research. Biol Pharm Bull 24 10 (2001) 1097-1101
11. Loprinzi C.L., Levitt R., Barton D.L., Sloan J.A., Atherton P.J., et al. Evaluation of Shark Cartilage in patients with advanced cancer: A North Central Cancer Treatment Group Trial (2005), Wiley Interscience Published online
12. Felzenszwalb I., Peleilo de Mattos J.C., Bernardo-Filho M., and Caldeira-de-Araujo A. Shark cartilage-containing preparation: protection against reactive oxygen species. Food Chem Toxicol 36 (1998) 1079-1084
13. Conde C.M.S., Albano F., Bouskela E., Felzenszwalb I., and Svensjo E. Inhibition of ischemia/reperfusion induced plasma leakage by alpha-tocopherol, trolox, and a shark cartilage preparation with anti-oxidant properties. Nutr Res 21 (2001) 1363-1371
14. Chen J.S., Chang C.M., Wu J.C., and Wang S.M. Shark cartilage extract interferes with cell adhesion and induces reorganization of focal adhesions in cultured endothelial cells. J Cell Biochem 78 (2000) 417-428
15. Ratel D., Glazier G., Provencal M., Boivin D., Beaulieu E., et al. Direct-acting fibrinolytic enzymes in shark cartilage extract: potential therapeutic role in vascular disorders. Thromb Res 115 1-2 (2005) 143-152
16. Feyzi R., Hassan Z., and Mostafaie A. Modulation of CD4+ and CD8+ tumor infiltrating lymphocytes by a fraction isolated from shark cartilage: shark cartilage modulates anti-tumor immunity. Int Immunopharmacol 3 (2003) 921-926
17. Kralovec J., Guan Y., Metera K., and Carr R.I. Immunomodulating principles from shark cartilage Part I. Isolation and biological assessment in vitro. Int Immunopharmacol 3 (2003) 657-669
18. Hassan Z., Feyzi R., Sheikhian A., Bargahi A., Mostafaie A., et al. Low molecular weight fraction of shark cartilage can modulate immune responses and abolish angiogenesis. Int Immunopharmacol 5 6 (2005) 961-970
19. Romagnani S. Immunologic influences on allergy and the Th1/Th2 balance. J Allergy Clin Immunol 113 3 (2004) 395-400
20. Muraille E., and Leo O. Revisiting the Th1/Th2 paradigm. Scand J Immunol 47 1 (1998) 1-9
21. Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev 8 3 (2003) 223-246
22. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., et al. Measurement of protein using bicinchoninic acid. Anal Biochem 150 (1985) 76-85
23. Nandan R., and Brown D.R. An improved in vitro pyrogen test: to detect picograms of endotoxin contamination in intravenous fluids using limulus amoebocyte lysate. J Lab Clin Med 89 4 (1977) 910-918
24. Aggarwal B.B., and Reddy S. Tumor necrosis factor. In: Nicola N.A. (Ed). Guidebook to cytokines and their receptors. A Sambrook and Tooze Publication of Oxford University Press (1994) 103-104
25. Gray P.W. Interferon Gamma. In: Nicola N.A. (Ed). Guidebook to cytokines and their receptors. A Sambrook and Tooze Publication of Oxford University Press (1994) 118-119
26. Tracey K.J., and Cerami A. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med 45 (1994) 491-503
27. Mosser D.M. The many faces of macrophage activation. J Leukoc Biol 73 2 (2003) 209-212
28. Wang J., Wakeham J., Harkness R., and Xing Z. Macrophages are a significant source of type 1 cytokines during mycobacterial infection. J Clin Invest 103 7 (1999) 1023-1029
29. Whiteside T.L. Cytokine measurements and interpretation of cytokine assays in human disease. J Clin Immunol 14 6 (1994) 327-339
30. Billiau A., Heremaus H., Vermeire K., and Matthys P. Immunomodulatory properties of interferon gamma: an update. Ann NY Acad Sci 856 (1998) 22-32
31. Maggi E., Parronchi P., Manetti R., Simonelli C., Piccinni M.P., et al. Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Th1 and Th2 clones. J Immunol 148 7 (1992) 2142-2147
32. Lund F.E., Garvey B.A., Randall T.D., and Harris D.P. Regulatory roles for cytokine-producing B cells in infection and autoimmune disease. Curr Dir Autoimmun 8 (2005) 25-54